Effects of Dapagliflozin on Symptoms, Function, and Quality of Life in Patients With Heart Failure and Reduced Ejection Fraction: Results From the DAPA-HF Trial.

Authors :: Kosiborod, Mikhail N.
Jhund, Pardeep S.
Docherty, Kieran F.
Diez, Mirta
Petrie, Mark C.
Verma, Subodh
Nicolau, Jose C.
Merkely, Béla
Kitakaze, Masafumi
DeMets, David L.
Inzucchi, Silvio E.
Køber, Lars
Martinez, Felipe A.
Ponikowski, Piotr
Sabatine, Marc S.
Solomon, Scott D.
Bengtsson, Olof
Lindholm, Daniel
Niklasson, Anna
Sjöstrand, Mikaela
Source :: Circulation; 1/14/2020, Vol. 141 Issue 2, p90-99, 10p
Publication Year :: 2020

Full Text Access

Tools